About Leber Congenital Amaurosis
Leber congenital amaurosis (LCA) encompasses a group of rare autosomal recessive or less commonly autosomal dominant inherited retinal dystrophies characterized by severe vision impairment or blindness present at birth or in early infancy. The condition results from mutations in genes encoding proteins critical for photoreceptor development and function, with over 25 different genetic subtypes identified to date.
These mutations lead to progressive degeneration of retinal photoreceptor cells—particularly cone and rod photoreceptors—resulting in severely compromised vision from the earliest months of life. Patients typically present with severe vision loss, nystagmus (involuntary eye movements), and abnormal pupillary responses. Over time, progressive retinal degeneration leads to complete vision loss in most cases. Clinical examination reveals pale, waxy optic discs and attenuated retinal vessels. Electroretinography shows nonrecordable or severely reduced responses in both photopic and scotopic conditions, a hallmark diagnostic finding. Fundus imaging demonstrates progressive retinal atrophy with variable presentation depending on the genetic subtype.
This genetic heterogeneity has critical implications for treatment, as recent gene therapies are subtype-specific and can only benefit patients carrying mutations in targeted genes. Early genetic testing is therefore essential for prognostication and accessing emerging therapies.
Common Symptoms of Leber Congenital Amaurosis
Recognizing the signs of Leber Congenital Amaurosis early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.
- Severe vision loss or blindness from birth or early infancy
- Nystagmus (involuntary eye movements)
- Photophobia (light sensitivity)
- Hyperopia and astigmatism
- Pupillary abnormalities
- Retinal degeneration on imaging
Who Leber Congenital Amaurosis Affects
Leber congenital amaurosis presents from birth or within the first few weeks to months of life. The condition affects males and females equally across all ethnic groups, though certain genetic subtypes and mutations show higher prevalence in specific populations. For example, LCA subtypes caused by mutations in genes like CEP290 and RPE65 are found worldwide, while some rarer subtypes show regional clustering.
Inheritance follows autosomal recessive patterns for the majority of cases, meaning both parents must carry mutations; less commonly autosomal dominant inheritance occurs. Rare X-linked inheritance patterns exist for specific subtypes.
Find Your Next Step
Answer a few questions and we'll point you to the right tools and information for where you are right now.
FDA-Approved Treatments for Leber Congenital Amaurosis
There is currently 1 FDA-approved medication for Leber Congenital Amaurosis. These therapies represent the current standard of care and may be used alongside or compared against investigational treatments in active clinical trials.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Help Paying for Leber Congenital Amaurosis Treatment
Charity funds and drugmaker programs for Leber Congenital Amaurosis, checked at the source. Pick your insurance to see what fits.
No charity fund for this condition is open right now. Funds reopen when they receive new donations; the foundations let you sign up to be told when one opens.
Side Effect Explorer
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Genetic Testing
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Leber Congenital Amaurosis Resources
Reputable organizations and medical references for learning more about Leber Congenital Amaurosis, including disease registries, foundation resources, and clinical guidelines.